Our Team

François Ravenelle, PhD

François Ravenelle, PhD Founder & CEO

Dr. Ravenelle is steering the comeback of cannabinoid receptor-1 (CB1) blockers at Inversago Pharma Inc. Pharmaceutical development professional and entrepreneur with 16 years of industrial R&D experience. Expertise in early-stage programs, from discovery to phase II, and also directly involved with an approved NDA.

Christine McCarthy, MD

Christine McCarthy, MD Acting Chief Medical Officer

Dr. McCarthy oversaw clinical development programs at Sanofi, including worldwide responsibility for rimonabant’s large Phase III program. Christine has more than 25 years of experience in large pharma companies.

Jean-Marie Vallet, PhD, MBA

Jean-Marie Vallet, PhD, MBA Acting Chief Business Development Officer

Dr. Vallet has over 30 years of experience in the pharma/biotech industry acquired across several functional areas including, Research, Business Development / Licensing, Strategic Planning, Corporate M&A and Finance & Administration.